Measuring medication adherence in older community-dwelling patients with multimorbidity
- 562 Downloads
Older people with several chronic conditions require multiple drugs from different classes to be adequately treated. This study aims to: (i) measure medication adherence across multiple conditions and therapeutic drug groups in older community-dwelling patients, and (ii) examine the effect of multimorbidity on adherence.
This is a retrospective cohort study of medication adherence in 855 community-dwelling patients aged ≥ 70 years from 15 practices in Ireland using the Health Service Executive Primary Care Reimbursement Service (HSE-PCRS) pharmacy claims database. Multimorbidity was measured using the RxRisk-V and by the number of different drug classes. The RxRisk-V algorithm classifies prescription drug fills into 45 chronic disease classes for older populations based on the WHO Anatomical Therapeutic Chemical classification system. Adherence to medications was assessed by: (i) calculating the average medication possession ratio (MPR) per patient and (ii) an MPR< 80%.
The overall median MPR for the cohort was 0.83 (IQR 0.69, 0.91). The conditions with the highest MPRs were hypothyroidism (mean MPR = 0.88, SD = 0.20) and type 2 diabetes (mean MPR = 0.83, SD = 0.19), followed by heart disease. On average, 20–40% of patients were non-adherent (MPR < 80%) across all conditions. There was an inverted U-shaped relationship between the mean MPR and number of morbidities and drug classes. Adherence varied per patients’ morbidity burden, with higher adherence for certain combinations of chronic conditions.
In total, 31% of older patients with multimorbidity were non-adherent to their medication but adherence levels varied across treatment categories and chronic conditions.
KeywordsMedication adherence Older people Multimorbidity MPR
We wish to thank all the study participants and the 15 general practices who kindly gave their time to take part in this study.
This study was funded by the HRB Research Leader award (RL-2015-1579) and HRB Centre for Primary Care Research (HRC/1/2007).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.Sabate E (2003) Adherence to long-term therapies: evidence for action. World Health Organization, GenevaGoogle Scholar
- 2.Giardini A, Martin MT, Cahir C, Lehane E, Menditto E, Strano M, Pecorelli S, Monaco A, Marengoni A (2016) Toward appropriate criteria in medication adherence assessment in older persons: position paper. Aging Clin Exp Res 28(3):371–381. https://doi.org/10.1007/s40520-015-0435-z CrossRefPubMedGoogle Scholar
- 6.Gottlieb H (2000) Medication nonadherence: finding solutions to a costly medical problem. Drug Benefit Trends 12(6):57–62Google Scholar
- 9.Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, Cadoret C, Fish LS, Garber L, Kelleher M, Bates DW (2003) Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 289(9):1107–1116. https://doi.org/10.1001/jama.289.9.1107
- 11.Choudhry NK, Shrank WH, Levin RL, Lee JL, Jan SA, Brookhart MA, Solomon DH (2009) Measuring concurrent adherence to multiple related medications. Am J Manag Care 15(7):457–464Google Scholar
- 12.Osterberg L, Blaschke T (2005) Adherence to medication. N Engl J Med 353(5):487–497. https://doi.org/10.1056/NEJMra050100
- 15.International Society of Pharmacoeconomics (2017) Methods of measuring multiple medication adherence: A systematic review. On line publication https://www.ispor.org/sigs/medication.asp
- 17.Central Statistics Office (2013) Women and Men in Ireland 2013: Persons with a medical card. Available at http://www.cso.ie/en/releasesandpublications/ep/pwamii/womenandmeninireland2013/healthlist/health/#d.en.65619
- 18.Sinnott S-J, Bennett K, Cahir C (2017) Pharmacoepidemiology resources in Ireland—an introduction to pharmacy claims data. Eur J Clin Pharmacol 73(11):1457. https://doi.org/10.1007/s00228-017-2358-4
- 19.Sloan KL, Sales AE, Liu CF, Fishman P, Nichol P, Suzuki NT, Sharp ND (2003) Construction and characteristics of the RxRisk-V: a VA-adapted pharmacy-based case-mix instrument. Med Care 41(6):761–774. https://doi.org/10.1097/01.MLR.0000064641.84967.B7
- 20.Johnson ML, El-Serag HB, Tran TT, Hartman C, Richardson P, Abraham NS (2006) Adapting the Rx-Risk-V for mortality prediction in outpatient populations. Med Care 44(8):793–797. https://doi.org/10.1097/01.mlr.0000218804.41758.ef
- 22.Cahir C, Fahey T, Teeling M, Teljeur C, Feely J, Bennett K (2010) Potentially inappropriate prescribing and cost outcomes for older people: a national population study. Br J Clin Pharmacol 69(5):543–552. https://doi.org/10.1111/j.1365-2125.2010.03628.x
- 23.Carey IM, De Wilde S, Harris T, Victor C, Richards N, Hilton SR et al (2008) What factors predict potentially inappropriate primary care prescribing in older people? Drugs Aging 25(8):639–706Google Scholar
- 27.Joint Formulary Committee (2015) British National Formulary. BMJ Group and Pharmaceutical Press, LondonGoogle Scholar
- 28.Briesacher BA, Andrade SE, Fouayzi H, Chan KA (2008) Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy 28(4):437–443. https://doi.org/10.1592/phco.28.4.437
- 29.Rolnick SJ, Pawloski PA, Hedblom BD, Asche SE, Bruzek RJ (2013) Patient characteristics associated with medication adherence. J Clin Med Res 11(2):54–65. https://doi.org/10.3121/cmr.2013.1113
- 32.Woolcott JC, Richardson KJ, Wiens MO, Patel B, Marin J, Khan KM, Marra CA (2009) Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med 169(21):1952–1960. https://doi.org/10.1001/archinternmed.2009.357
- 33.Choudhry NK, Fischer MA, Avorn J, Liberman JN, Schneeweiss S, Pakes J, Brennan TA, Shrank WH (2011) The implications of therapeutic complexity on adherence to cardiovascular medications. Arch Intern Med 171(9):814–822Google Scholar
- 34.Grant RW, O'Leary KM, Weilburg JB, Singer DE, Meigs JB (2004) Impact of concurrent medication use on statin adherence and refill persistence. Arch Intern Med 164(21):2343–2348. https://doi.org/10.1001/archinte.164.21.2343
- 36.Burroughs H, Lovell K, Morley M, Baldwin R, Burns A, Chew-Graham C (2006) ‘Justifiable depression’: how primary care professionals and patients view late-life depression? A qualitative study. Fam Pract 23(3):369–377. https://doi.org/10.1093/fampra/cmi115
- 37.Ellis G, Whitehead MA, Robinson D, O’Neill D, Langhorne P (2011) Comprehensive geriatric assessment for older adults admitted to hospital: meta-analysis of randomised controlled trials. BMJ 343–352:d6553. https://doi.org/10.1136/bmj.d6553
- 39.National Institute for Clinical Excellence (2016) Multimorbidity: clinical assessment and management. This is a report https://www.nice.org.uk/guidance/ng56
- 40.Moriarty F, Hardy C, Bennett K, Smith SM, Fahey T (2015) Trends and interaction of polypharmacy and potentially inappropriate prescribing in primary care over 15 years in Ireland: a repeated cross-sectional study. BMJ Open 5(9):e008656. https://doi.org/10.1136/bmjopen-2015-008656
- 41.Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A, et al (2014) Interventions for enhancing medication adherence. Cochrane Database Syst Rev (11):Cd000011Google Scholar
- 42.Murray MD, Young J, Hoke S, Tu W, Weiner M, Morrow D, Stroupe KT, Wu J, Clark D, Smith F, Gradus-Pizlo I, Weinberger M, Brater DC (2007) Pharmacist intervention to improve medication adherence in heart failure: a randomized trial. Ann Intern Med 146(10):714–725Google Scholar